Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jonathan L Moore"'
Autor:
Ben E. Byrne, James A. Gossage, Andrew R Davies, Joanna Taylor, Jason M Dunn, Annabelle White, Orla Evans, Jonathan L Moore, Cara R. Baker, Annie Coombes, Phillip H Pucher, Jesper Lagergren, Mark Kelly, Jervoise Andreyev, Sebastian Zeki
Purpose: Long-lasting symptoms and reductions in quality of life are common after oesophago-gastric surgery. Post-operative follow-up has traditionally focussed on tumour recurrence and survival, but there is a growing need to also identify and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a01f0ecc84136b715702fbcfdbcf8dc6
https://doi.org/10.21203/rs.3.rs-1054245/v1
https://doi.org/10.21203/rs.3.rs-1054245/v1
Autor:
Philip H, Pucher, Annie, Coombes, Orla, Evans, Joanna, Taylor, Jonathan L, Moore, Annabelle, White, Jesper, Lagergren, Cara, Baker, Mark, Kelly, James A, Gossage, Jason, Dunn, Sebastian, Zeki, Ben E, Byrne, Jervoise, Andreyev, Andrew R, Davies
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(6)
Long-lasting symptoms and reductions in quality of life are common after oesophago-gastric surgery. Post-operative follow-up has traditionally focussed on tumour recurrence and survival, but there is a growing need to also identify and treat function
Autor:
Moore JL; Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Santaolalla A; Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Van Hemelrijck M; Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., North B; Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Davies AR; Jonathan L. Moore, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; Aida Santaolalla, PhD, Mieke Van Hemelrijck, PhD, and Bernard North, PhD, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom; and Andrew R. Davies, MD, FRCS, Department of Upper Gastrointestinal and General Surgery, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 20; Vol. 42 (3), pp. 367-368. Date of Electronic Publication: 2023 Nov 21.